SCHEMBL18777987

SCHEMBL18777987

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cccc(-c3cccc(-c4cccc(-c5cnc6c7ccccc7c7ccccc7c6n5)c4)c3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSPO P30536 1/20 0.33
ASIC3 Q9UHC3 1/20 0.33
PTGER4 P35408 1/20 0.32
PDE10A Q9Y233 1/20 0.32
NPY5R Q15761 1/20 0.32
DHFR P00374 1/20 0.32
NR3C1 P04150 1/20 0.32
MAPT P10636 1/20 0.31
NPC1 O15118 1/20 0.31
PDGFRB P09619 1/20 0.31
KDR P35968 1/20 0.31
FLT3 P36888 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18777869 1.00 KDM4E (0.37) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL12268596 0.99 KDM4E (0.38) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL12268606 0.99 KDM4E (0.38) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL17464165 0.98 KDM4E (0.40) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL17464157 0.98 KDM4E (0.40) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL17456840 0.98 KDM4E (0.40) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL17464155 0.98 KDM4E (0.40) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL17464150 0.98 KDM4E (0.40) KDM4EATML3MBTL1TSPOASIC3
SCHEMBL16543816 0.98 KDM4E (0.36) KDM4EATML3MBTL1TSPOPTGER4
SCHEMBL18777940 0.98 ASIC3 (0.34) KDM4EATML3MBTL1ASIC3PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11522138-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2022-12-06 US disclosed
US-20170117487-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed
US-20170117487-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170117487-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device RECQL, HSF1, DDX41 KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885
US-11522138-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device RECQL, HSF1, DDX41 KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.